Meet the Team

We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, we brought together the most experienced management team, renowned scientists, industry leading investors and expert advisors, to form a collaborative ecosystem, united through the common goal of advancing the science of precision health.

Kevin Hrusovsky

Chairman and Chief Executive Officer

Dawn R. Mattoon, PhD

Senior Vice President, Clinical Diagnostics

Denise Chittick

Chief Human Resources Officer

Masoud Toloue, PhD

President of Quanterix and Diagnostics

Mark Roskey, PhD

Senior Vice President, Translational Collaborations & Customer Experience

Michael Doyle

Chief Financial Officer

John Fry, JD

General Counsel and Corporate Secretary

Richard Haigh, PhD

Senior Vice President, Research Products

Gerrit Smith

Senior Vice President of Operations

Brian Keane, JD

Senior Vice President and Senior Legal Counsel

David Duffy, PhD

Vice President, Research and Chief Technology Officer

Kristine Klinger

Vice President, Enterprise Program Management Office

Kevin Hrusovsky

Chairman and Chief Executive Officer

Martin Madaus, PhD

Chief Operations Officer, Sherlock Biosciences, Inc.

Keith L. Crandell

Co-Founder & Managing Director, ARCH Venture Partners

David Walt, PhD

Senior Investigator, Brigham and Women’s Hospital, Department of Pathology, Core Faculty Member-Wyss Institute, Harvard Medical School at Harvard University

Paul Meister

Co-founder and Chief Executive Officer, Liberty Lane Partners, LLC

Marijn Dekkers

Chairman of Novalis LifeSciences

Sarah Hlavinka

Senior Vice President and General Counsel, Itron

Laurie Olson

Former Executive Vice President of Strategy and Commercial Operations at Pfizer, Inc.

Ready to take your biomarker research to the next level?

request a quote